Golimumab - CAS 476181-74-5

Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1β, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer.

Apoptosis, Caspase, Interleukin, TNF

Immunology/Inflammation, Apoptosis, Proteases/Proteasome

476102

0.997

-20°C

Ice Packs

Inhibitory Antibodies